Self-Reported Health-Related Quality of Life and Residual Symptoms among Virologically Suppressed People Living with HIV in the Era of Single-Tablet Regimens in Taiwan: A Cross-Sectional Study

Chien-Yu Cheng,Hsiu-Yin Wang,Chia-Jui Yang
DOI: https://doi.org/10.3390/life14030294
2024-02-22
Life
Abstract:This study assessed the health-related quality of life (HRQoL) and residual symptom burden among virologically suppressed people living with human immunodeficiency virus (HIV) (PLWH) using a single-tablet regimen in Taiwan. This cross-sectional study administered a self-reported online survey between July and October 2021 to anonymised virologically suppressed PLWH aged ≥20 years. Demographic, HIV-related variables, EuroQol-5-dimensions (EQ-5D), visual analogue scale (VAS), and HIV Symptom Index were analysed. Bivariate analyses were performed to compare HRQoL differences between PLWH and non-PLWH. Among 120 PLWH, 80.9% had HIV diagnosis for <15 years, median antiretroviral therapy (ART) duration of 7.0 years (Q1–Q3:4.0–11.0), and 62.5% had ≥1 comorbidity. The most common comorbidities were depression (26.7%) and hyperlipidaemia (15.8%). About one-fifth of PLWH received constant family support (25.8%) and peer support (21.7%). Married individuals or individuals with higher incomes had significantly better family support status. There was no significant difference across the five dimensions between PLWH and non-PLWH. PLWH perceived being bothered by fatigue/lack of energy (63.3%), sleep difficulties (63.3%), feeling sad/low/unhappy (51.7%), and appearance changes (51.7%). PLWH could achieve similar HRQoL as non-PLWH with stable treatment, highlighting an opportunity to focus on person-centred holistic care beyond HIV, especially on the psychological aspect, for the best possible HRQoL for PLWH.
biology
What problem does this paper attempt to address?
This paper aims to explore the quality of life and related factors of people living with human immunodeficiency virus (HIV) in Taiwan who are undergoing virological suppression with single-tablet regimens (STRs). Specifically, the study assesses the self-reported health-related quality of life (HRQoL) and residual symptom burden of these HIV patients through a cross-sectional survey. ### Research Objectives 1. **Assess HRQoL**: The study evaluates the quality of life of HIV patients who are receiving single-tablet regimen treatment and have achieved virological suppression. 2. **Understand Residual Symptoms**: It explores whether these HIV patients have any residual symptom burden. 3. **Compare HRQoL**: The HRQoL of HIV patients is compared with that of non-HIV individuals to understand if there are any differences. 4. **Analyze Influencing Factors**: The study investigates factors that may influence HRQoL, such as family support, peer support, and social support. ### Key Findings - **HRQoL Similarity**: The quality of life of HIV patients is similar to that of non-HIV individuals, indicating that good quality of life can be achieved under stable treatment. - **Residual Symptom Burden**: Despite achieving virological suppression, HIV patients still experience some common residual symptoms, such as fatigue, sleep difficulties, depressive mood, and changes in appearance. - **Psychological Concerns**: The study emphasizes the need to pay more attention to the psychological health of HIV patients, particularly in areas such as depression and anxiety, to improve their overall quality of life. - **Importance of Social Support**: Family support is crucial for improving the quality of life and obtaining support for HIV patients, while social support is relatively weaker. ### Conclusion The study reveals that even under virological suppression, HIV patients still face certain challenges, especially in terms of psychological health. Therefore, more comprehensive care measures are needed, focusing not only on virological control but also on the psychological health and social support needs of patients to achieve optimal quality of life.